Cargando…
Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention
This article examines how biomedicalisation is encountered, responded to and negotiated within and in relation to new biomedical forms of HIV prevention. We draw on exploratory focus group discussions on pre‐exposure prophylaxis (PrEP) and treatment as prevention (TasP) to examine how the processes...
Autores principales: | Young, Ingrid, Flowers, Paul, McDaid, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102670/ https://www.ncbi.nlm.nih.gov/pubmed/26498141 http://dx.doi.org/10.1111/1467-9566.12372 |
Ejemplares similares
-
Navigating HIV citizenship: identities, risks and biological citizenship in the treatment as prevention era
por: Young, Ingrid, et al.
Publicado: (2019) -
How Acceptable are Antiretrovirals for the Prevention of Sexually Transmitted HIV?: A Review of Research on the Acceptability of Oral Pre-exposure Prophylaxis and Treatment as Prevention
por: Young, Ingrid, et al.
Publicado: (2013) -
Awareness and Willingness to Use HIV Pre-Exposure Prophylaxis amongst Gay and Bisexual Men in Scotland: Implications for Biomedical HIV Prevention
por: Young, Ingrid, et al.
Publicado: (2013) -
Key factors in the acceptability of treatment as prevention (TasP) in Scotland: a qualitative study with communities affected by HIV
por: Young, I, et al.
Publicado: (2015) -
Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland
por: Young, Ingrid, et al.
Publicado: (2014)